Financials
- Market Capitalization 4.6 M
- Employee 7
- Founded 2016
- CEO N/A
- Website www.alzamend.com
- Headquarter Delaware, United States
- FIGI BBG00ZMXG7M8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.52
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4987 | ENVB Enveric Biosciences, Inc. - Common Stock | 1.30 USD | -0.76% | -10.34% | -18.75% | -47.05% | 4.79 M USD | ||
| 4997 | CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 0.36 USD | +2.86% | 0.00% | +5.88% | -77.64% | 4.61 M USD | ||
| 4999 | MBIO Mustang Bio, Inc. - Common Stock | 0.66 USD | 0.00% | -7.04% | -9.59% | -23.96% | 4.78 M USD | ||
| 5002 | LIMN Liminatus Pharma, Inc. - Class A Common Stock | 0.10 USD | -9.09% | -23.08% | -16.67% | -98.36% | 4.49 M USD |